The airline industry is on a flight path for higher altitude this year, as economic recovery fuels demand for travel among newly con颅fident consumers.
Last year, the industry racked up revenue of $637 billion and earnings of $6.7 billion. Despite these gains, stocks of the strongest carriers are trading at at颅tractive valuations, making this a good time to grab a cheap seat on the sector�� upward trajectory. Below, we look at two of the most promising airlines.
Delta Air Lines (DAL)
Delta, the world�� second-largest airline, commands a growing domestic and international presence.
Top 10 Life Sciences Stocks To Buy For 2016: Chesapeake Lodging Trust (CHSP)
Chesapeake Lodging Trust (the Trust) is a self-advised real estate investment trust (REIT). The Trust is focused on investments primarily in upper-upscale hotels in business and convention markets and, on a selective basis, select-service and extended-stay hotels in urban settings or locations in the United States of America. All of the Trust�� assets are held by, and all of its operations are conducted through, Chesapeake Lodging, L.P., its operating partnership (the Operating Partnership). The Operating Partnership leases its hotels to CHSP TRS LLC (CHSP TRS), which is a wholly owned subsidiary of the Operating Partnership. CHSP TRS engages hotel management companies to operate the hotels pursuant to management agreements. CHSP TRS is a taxable REIT subsidiary (TRS). As of December 31, 2011, the Trust owned 12 hotels with an aggregate of 3,516 rooms in six states and the District of Columbia. In August 2012, the Company acquired the 520-room W Chicago-Lakeshore located in Chicago, Illinois from Starwood Hotels & Resorts Worldwide Inc. (Starwood). The Trust entered into a long-term management agreement with Starwood to continue operating the hotel under the W flag. In September 2012, it acquired the 429-room Hyatt Regency Mission Bay Spa and Marina, located in San Diego, California. In October 2012, the Company acquired 222-room The Hotel Minneapolis, a Marriott Autograph Collection hotel, located in Minneapolis. In March 2013, the Company acquired 185-room Hyatt Place New York Midtown South, located in New York. In April 2013, Starwood Hotels & Resorts Worldwide Inc completed the sale of W New Orleans - French Quarter to Chesapeake Lodging Trust. In April 2013, Chesapeake Lodging Trust acquires W New Orleans From Starwood Hotels & Resorts Worldwide Inc. In June 2013, Chesapeake Lodging Trust purchased the Hyatt Fisherman's Wharf from Hyatt Hotels Corp. Effective June 27, 2013, Chesapeake Lodging Trust acquired Hyatt Santa Barbara.
On December 22, 2011, the Trust acquired Holiday Inn ! New York City Midtown, which had 122 rooms. On October 3, 2011, the Trust acquired Denver Marriott City Center hotel, which had 613 rooms. On July 8, 2011, it acquired Hotel Adagio, which consisted of 171 rooms. On June 30, 2011, the Trust acquired Courtyard Washington Capitol Hill/Navy Yard hotel, which had 204 rooms. On June 17, 2011, it acquired Hotel Indigo San Diego Gaslamp Quarter, which consisted of 210 rooms. On May 10, 2011, the Trust acquired W Chicago - City Center hotel, which had 368 rooms. On May 2, 2011, it acquired Homewood Suites Seattle Convention Center hotel, which had 195 rooms.
The Company has management agreements with third parties to manage its hotels. The Trust's hotel managers provide managerial and other hotel employees, oversee operations and maintenance, prepare reports, budgets and projections and provide other administrative and accounting support services. Its management agreements provide for base management fees ranging from 1% to 4% of gross hotel revenues and incentive compensation if hotel operating income. Of its 12 hotels, seven operates pursuant to franchise agreements from international hotel companies. The Trust�� lease agreements are inter-company agreements between its property-owning subsidiaries and its TRS lessees.
Advisors' Opinion:- [By Rich Duprey]
Real estate investment trust�Chesapeake Lodging Trust� (NYSE: CHSP ) �announced yesterday its second-quarter dividend of $0.24 per share, the same rate it paid last quarter after raising the payout 9% from $0.22 per share.
Best Promising Companies For 2015: FibroGen Inc (FGEN)
FibroGen, Inc. (FibroGen) is a research-based biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics to treat unmet medical needs. The Company focuses in the areas of fibrosis and hypoxia-inducible factor (HIF) biology. FibroGen�� products include Roxadustat (FG-4592), which is an oral small molecule inhibitor of HIF prolyl hydroxylases (HIF-PHs), in Phase III clinical development for the treatment of anemia in chronic kidney disease (CKD), and FG-3019, which is a monoclonal antibody in Phase II clinical development for the treatment of idiopathic pulmonary fibrosis (IPF), pancreatic cancer and liver fibrosis. The Company�� subsidiaries include FibroGen Europe Oy (FibroGen Europe) and FibroGen China Anemia Holdings, Ltd. (FibroGen China).
Roxadustat is the HIF-PH inhibitor in Phase III clinical development, which acts by stimulating the body�� natural pathway of erythropoiesis, or red blood cell production. Roxadustat represents a new paradigm for the treatment of anemia in CKD patients and offers injectable erythropoiesis stimulating agents (ESAs). 1,449 subjects have participated in 26 completed Phase I and II clinical studies for roxadustat in North America, Europe and Asia. The Company, along with its collaboration partners, Astellas Pharma Inc., (Astellas) and AstraZeneca AB,(AstraZeneca), has designed a global Phase III program to support regulatory approval of roxadustat in both NDD-CKD and DD-CKD patients in multiple geographies.
FG-3019 is the Company�� fully-human monoclonal antibody that inhibits the activity of connective tissue growth factor (CTGF), a critical common element in the progression of fibrosis and associated diseases. In Phase II IPF clinical studies, FG-3019 demonstrated the stabilization of disease and, in human studies, reversal of lung fibrosis in some patients. In an open-label Phase II pancreatic cancer study of FG-3019 plus gemcitabine and erlotinib, FG-3019 demonstrated a dose-depen! dent improvement in one year survival rate. In 10 Phase I and Phase II clinical studies of FG-3019 to date involving over 340 subjects, FG-3019 has been tolerated across a range of doses studied, and there have been no dose-limiting toxicities observed as of November 13, 2014.
The Company competes with Threshold Pharmaceuticals, Inc., Gilead Sciences, Inc., Halozyme Therapeutics, Inc., Gilead Sciences, Inc., Celgene Corporation, Janssen Biotech, Inc., Johnson & Johnson, Inc., Sanofi, Novartis and Biogen Idec.
Advisors' Opinion:- [By John Udovich]
Recent IPO�FibroGen Inc (NASDAQ: FGEN) surged 22.96% today, reportedly after the journal Hepatology published the results of a workshop between the FDA and the American Association for the Study of Liver Disease (AASLD) which laid out criteria for a phase three study of a treatment for non-alcoholic steatohepatitis (NASH)���meaning its worth taking a closer look at the stock along with the performance of potential small cap or mid cap liver disease stock peers like Conatus Pharmaceuticals Inc (NASDAQ: CNAT), Intercept Pharmaceuticals Inc (NASDAQ: ICPT) and Raptor Pharmaceutical Corp (NASDAQ: RPTP) which rose 24.35%, 10.98% and 2.02%, respectively. According to Investors Business Daily, NASH (the more serious version of fatty liver disease) is potentially an enormous market with about 6 million�US patients but the�lack of previous treatments had left it unclear how the FDA would measure success against the disease while FibroGen Inc doesn't yet have a NASH human trial in the works, it has said it hopes to start one for its lead candidate FG-3019 (its in mid-stage trials for pulmonary fibrosis and liver fibrosis due to hepatitis B infection).
Best Promising Companies For 2015: Hybrid Coating Technologies Inc (HCTI)
Hybrid Coating Technologies Inc. (HCT), incorporated on November 2, 2011, is a development-stage company. The Company's business is that of its wholly owned subsidiary, Nanotech Industries International Inc. (Nanotech). This business is the manufacturing and sale of alternative non-toxic (isocyanate-free) polyurethane, Green Polyurethane. The products manufactured and sold by the Company (Nanotech Products) comprise coating products and sealant products. Coatings and raw binder ingredients comprised of Green Polyurethane Monolithic Floor Coating and Green Polyurethane Binder and referred to as Coating Products. Sealants and adhesives comprised of Green Polyurethane and referred to as Sealant Products.
Applications for Green Polyurethane products markets include industrial and commercial buildings; civil applications for tunnels and bridges; private and public garages; chemical and food processing plants; Warehouses; Monolithic floorings for civil, industrial and military engineering; marine and aeronautic applications; industrial equipment for dairy and liquid fertilizer processing plants and delivery systems; military facilities and equipment, and protective coatings inside industrial and commercial pipes. The Company intends to establish full commercial-scale manufacturing for both of its products at Adhpro Adhesives Inc. (Adhpro Adhesives) in Magog, Quebec and Simpson Coatings Group Inc. (Simpson Coatings) in California through non-exclusive toll manufacturing agreements.
The Company competes with BASF, Sherwin Williams, PPG, Benjamin Moore, AKZO Nobel, Rust-Oleum and Sika AG.
Advisors' Opinion:- [By Peter Graham]
Last Friday, small cap stocks Tristar Wellness Solutions Inc (OTCMKTS: TWSI) jumped 14.94% while Hybrid Coating Technologies (OTCBB: HCTI) and Bulova Technologies Group, Inc (OTCMKTS: BTGI) sank 23.53% and 13.04%, respectively. It should be mentioned that only one of these small cap stocks appears to be the subject of paid promotions or investor relations type activities. So what will these three small cap stocks do for investors this week? Here is a quick reality check to help you decide on a trading or investing strategy:
- [By Peter Graham]
Small cap green stocks Hybrid Coating Technologies, Inc (OTCBB: HCTI), Pan Global Corp (OTCMKTS: PGLO) and Trans Global Group Inc (OTCMKTS: TGGI) have been getting some attention lately in various investment newsletters or alerts with two of these stocks also being the subject of some paid promotions. But will these small cap green stocks actually deliver some green in the form of greenbacks for investors? Let�� take off the green eyeshades and take a closer look:
Hybrid Coating Technologies, Inc (OTCBB: HCTI) Has Expanded Its Green TechnologySmall cap Hybrid Coating Technologies, Inc is a San Francisco-based innovator focused on improving the quality and safety of coatings and paint for industrial and commercial customers around the world and it�� the exclusive licensee of Green Polyurethane(TM) coatings and paint - the world's first-ever patent protected polyurethane-based coatings and paint products which eliminate toxic isocyanates from the entire production process (licensed by Nanotech Industries, Inc). On Friday, Hybrid Coating Technologies, Inc rose 2.13% to $0.48 for a market cap of $44.27 million plus HCTI is up 20% over the past year and down 96.9% since August 2009 according to Google Finance.
Best Promising Companies For 2015: Morgan Stanley Emerging Markets Fund Inc. (MSF)
Morgan Stanley Emerging Markets Fund, Inc. is a closed-ended equity mutual fund launched and managed by Morgan Stanley Investment Management Inc. It invests in the public equity markets across the global emerging markets. The fund invests in stocks of companies operating across diversified sectors. It makes its investments in companies across all market capitalizations. The fund benchmarks the performance of its portfolio against the MSCI Emerging Markets Free Index. Morgan Stanley Emerging Markets Fund Inc. was formed on November 1, 1991 and is domiciled in the United States.
Advisors' Opinion:- [By George Putnam, Editor, New Generation Research, Inc.]
Morgan Stanley Emerging Markets Fund (MSF) is not an index-based fund, and therefore, its portfolio managers have a lot of latitude.
Among their top ten holdings are a range of consumer and technology holdings, such as Samsung Electronics and Taiwan Semiconductor, as well as financials. At current prices, the fund is trading at a roughly 10.5% discount to its net asset value (NAV).
Best Promising Companies For 2015: ChinaCache International Holdings Ltd.(CCIH)
ChinaCache International Holdings Ltd. provides Internet content and application delivery services to businesses, government agencies, and enterprises in China. It offers Web Page Content Services to website operators; file transfer services; rich media streaming services that enable live streaming of media files; guaranteed application services for websites that incorporate applications with features, such as on-line booking and ordering, real-time stock quotes, and on-line surveys; managed internet data services; ChinaCache cloud services; and content bridging services. The company also provides various value-added services, such as geo-content acceleration services, performance evaluation module, scalable services routing services, link anti-hijack services, NetStorage services, user behavior analysis services, and Website performance evaluation services. The company was founded in 1998 and is headquartered in Beijing, the People?s Republic of China.
Advisors' Opinion:- [By Eric Volkman]
ChinaCache International Holdings (NASDAQ: CCIH ) wants to spend money on its own shares after all. The company announced that its board has authorized a resumption of its stalled $10 million American Depositary Shares buyback program. It has plenty left in the tank. When halted, ChinaCache had spent only $1.5 million on such purposes.
Best Promising Companies For 2015: EMS Seven Seas ASA (EMS)
EMS Seven Seas ASA, formerly known as Eitzen Maritime Services ASA, is a Norway-based company active in the shipping industry. It is operational through two divisions: Ship Management and Ship Supply, servicing clients within the military, merchant, fisheries, offshore and cruise market segments. The Ship Management (and Insurance) unit provides technical management, crewing, newbuilding and project consultancy services, ship agency services and marine insurance brokering. It has its main operations in the Baltic, Russia, India and Singapore. Ship Supply provides provisions, duty free products, stores, spares and marine products and equipment to the merchant marine, offshore, fishing fleet, military and cruise market. This segment operates in Norway, Germany, the Netherlands, Spain, the United Arab Emirates (UAE), Djibouti and Singapore. Eitzen Maritime Services ASA is active internationally through its subsidiaries. Advisors' Opinion:- [By victorselva]
In a macro view, revenues in the electronic equipment and instrument sub-industry will remain strong due to the rise in equipment and instrument manufacturers. Distributors, electronic manufacturing service (EMS) companies and original equipment manufacturers (OEM) are going to increase orders as the economy improves in the future. With this promising outlook, let's take a look at Gabelli麓s last trade and try to explain to investors the reasons of this appealing investment opportunity.
Best Promising Companies For 2015: LRAD Corporation(LRAD)
LRAD Corporation engages in the design, development, and commercialization of directed sound technologies and products in North America, Europe, the Middle East, and Asia. The company develops and delivers directed acoustic products that beam, focus, and control sound over short and long distances. It offers Long Range Acoustic Device, which creates directed acoustic beam to communicate at operational ranges in high ambient noise environments, primarily for military applications. The company also provides SoundSaber thin film magnetic speaker technology that provides high clarity throughout the audio range for emergency and mass notification, public address, and other sound applications. Its SoundSaber hardened panels are used in acoustic environments, such as hangar bays, industrial buildings, airports, and other facilities. LRAD Corporation sells its products directly to government, military, large end-users, and defense-related companies. The company was formerly known as American Technology Corporation and changed its name to LRAD Corporation in March 2010. LRAD Corporation was founded in 1980 and is based in San Diego, California.
Advisors' Opinion:- [By gurujx]
LRAD (LRAD): CFO/Secretary Katherine McDermott Sold 38,204 Shares
CFO/Secretary Katherine McDermott sold 38,204 shares of LRAD stock on Aug. 28 at the average price of $1.57. Katherine H McDermott owns at least 17,800 shares after this. The price of the stock has decreased by 10.19% since.
No comments:
Post a Comment